Inventor · disambiguated record
Huw M. Nash
Also filed as: NASH HUW M
35 granted patents·35 pending applications·737 citations·filing 1998–2023
98Inventor score
Files withAILERON THERAPEUTICS INC36NASH HUW M16COLD SPRING HARBOR LABORATORY2NEOGENESIS PHARMACEUTICALS INC2SCHERING CORP2
Top patents by PatentIndex Score
70 records- 0199US7981999B2Triazole macrocycle systemsAILERON THERAPEUTICS INC·Filed 2008·Granted Jul 19, 2011·54 cites·59 claims
- 0298US9957296B2Triazole macrocycle systemsAILERON THERAPEUTICS INC·Filed 2016·Granted May 1, 2018·13 cites·8 claims
- 0398US9493509B2Triazole macrocycle systemsAILERON THERAPEUTICS INC·Filed 2015·Granted Nov 15, 2016·17 cites·23 claims
- 0498US8637686B2Triazole macrocycle systemsNASH HUW M·Filed 2011·Granted Jan 28, 2014·37 cites·21 claims
- 0598US7960506B2Bis-sulfhydryl macrocyclization systemsAILERON THERAPEUTICS INC·Filed 2007·Granted Jun 14, 2011·51 cites·22 claims
- 0697US9175047B2Peptidomimetic macrocyclesNASH HUW M·Filed 2010·Granted Nov 3, 2015·28 cites·9 claims
- 0797US9023988B2Triazole macrocycle systemsNASH HUW M·Filed 2012·Granted May 5, 2015·28 cites·41 claims
- 0897US8609809B2Bis-sulfhydryl macrocyclization systemsNASH HUW M·Filed 2010·Granted Dec 17, 2013·33 cites·26 claims
- 0997US8399405B2Peptidomimetic macrocyclesNASH HUW M·Filed 2012·Granted Mar 19, 2013·46 cites·28 claims
- 1096US8927500B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2013·Granted Jan 6, 2015·44 cites·105 claims
- 1196US7981998B2Bis-sulfhydryl macrocyclization systemsAILERON THERAPEUTICS INC·Filed 2008·Granted Jul 19, 2011·47 cites·28 claims
- 1295US9675661B2Bis-sulfhydryl macrocyclization systemsAILERON THERAPEUTICS INC·Filed 2015·Granted Jun 13, 2017·16 cites·17 claims
- 1395US9175056B2Bis-sulfhydryl macrocyclization systemsAILERON THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·27 cites·21 claims
- 1495US9175045B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·30 cites·31 claims
- 1595US8808694B2Therapeutic peptidomimetic macrocyclesNASH HUW M·Filed 2012·Granted Aug 19, 2014·37 cites·16 claims
- 1694US11096956B2Antisense oligomers and uses thereofSTOKE THERAPEUTICS INC·Filed 2018·Granted Aug 24, 2021·11 cites·20 claims
- 1794US10030049B2Triazole macrocycle systemsAILERON THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·11 cites·18 claims
- 1894US8524653B2Peptidomimetic macrocyclesNASH HUW M·Filed 2009·Granted Sep 3, 2013·37 cites·25 claims
- 1993US10022422B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Granted Jul 17, 2018·12 cites·12 claims
- 2092US9458202B2Peptidomimetic macrocycles with improved propertiesNASH HUW M·Filed 2009·Granted Oct 4, 2016·18 cites·18 claims
- 2192US9206223B2Methods for preparing purified polypeptide compositionsNASH HUW M·Filed 2009·Granted Dec 8, 2015·28 cites·47 claims
- 2291US11083745B2Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet SyndromeCOLD SPRING HARBOR LABORATORY·Filed 2016·Granted Aug 10, 2021·6 cites·36 claims
- 2391US9505804B2Peptidomimetic macrocyclesAILERON THERAPEUTICS·Filed 2014·Granted Nov 29, 2016·22 cites·71 claims
- 2491US9394336B2Methods for preparing purified polypeptide compositionsNASH HUW M·Filed 2012·Granted Jul 19, 2016·23 cites·39 claims
- 2584US7173046B2CD40:CD154 binding interrupter compounds and use thereof to treat immunological complicationsBIOGEN INC·Filed 2003·Granted Feb 6, 2007·22 cites·6 claims
- 2682US10967042B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·1 cites·18 claims
- 2782US2024124518A1Methods for preparing purified polypeptide compositionsAILERON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2880US10213477B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·2 cites·21 claims
- 2980US2023119612A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3077US10328117B2Bis-sulfhydryl macrocyclization systemsAILERON THERAPEUTICS INC·Filed 2017·Granted Jun 25, 2019·1 cites·20 claims
- 3176US10300109B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Granted May 28, 2019·1 cites·6 claims
- 3275US10246491B2Peptidomimetic macrocycles and use thereof in regulating HIF1alphaAILERON THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·1 cites·3 claims
- 3374US2022000968A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3473US2022017569A1Methods for preparing purified polypeptide compositionsAILERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3569US2009326192A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3668US6207861B1Method for producing and screening mass coded combinatorial libraries for drug discovery and target validationNEOGENESIS INC·Filed 1998·Granted Mar 27, 2001·30 cites·15 claims
- 3766US2022088058A1Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndromeCOLD SPRING HARBOR LABORATORY·Filed 2021·Application pending·0 cites
- 3865US2022118000A1Antisense oligomers and uses thereofSTOKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3965US2009275519A1Therapeutic peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 4064US2014323701A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4164US2018339014A1Peptidomimetic macrocyclesALLERON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4263US2017298099A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4362US7269519B2Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validationSCHERING CORP·Filed 2003·Granted Sep 11, 2007·0 cites·23 claims
- 4462US2013023646A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4561US2015038430A1Therapeutic peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4660US2019071469A1Therapeutic peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4758US2016068573A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4858US2017299576A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4956US2019225650A1Peptidomimetic macrocycles and use thereof in regulating hif1alphaAILERON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 5055US2016096873A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →